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The circadian system is key for optimal functioning by maintaining synchrony between internal 
circadian rhythms, behaviors, and external cues. Many clinicians are not fully aware, however, of the 
far-reaching implications of the circadian system for human health. Clinical attention to circadian 
rhythms has largely focused on insomnia symptoms. The impact of the circadian system on health is, 
however, much broader. Clinical diagnoses are often based on single time point assessments during 
the day, ignoring circadian influences on physiology. Even when time is considered, using (external) 
clock time ignores the large inter-individual differences in internal timing. Recent advances in 
techniques for the estimation of circadian phase now make it feasible to include circadian timing in 
clinical diagnosis and in the treatment of disease.  
 
Although the circadian system was previously considered a single oscillator, it is now recognised as a 
multi-oscillator system. In addition to the central pacemaker in the hypothalamic suprachiasmatic 
nucleus (SCN); peripheral oscillators exist in virtually every organ and cell of the body1. Circadian 
misalignment, referring to abnormal timing between SCN rhythms and behavior (e.g., sleeping during 
the biological day), the environment (e.g., exposure to light during the biological night), or peripheral 
oscillators, and between different peripheral oscillators (Figure 1c).  
 
Recently, the Nobel Prize in Physiology or Medicine was awarded to three pioneers in circadian 
biology for their ground-breaking work unravelling the molecular mechanisms of the circadian clock. 
The Nobel Prize Committee recognized not only the value of uncovering the mechanisms that drive 
circadian rhythms, but also their important health implications. In modern society, circadian 
misalignment is common and is associated with poor health1,2. Night shift work is an example of 
circadian misalignment caused by occupational requirements (Figure 1a). Individuals are required to 
work during the biological night, and sleep during the biological day, when sleep propensity and 
quality are low. Night work is highly prevalent, reported in about 14% of the working population. The 
societal impact of shift work is extensive, including high rates of chronic disease, increased healthcare 
costs, poor quality of life, and increased risk of—sometimes catastrophic—accidents3. 
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Many disease states may be caused or exacerbated by exposure to circadian misalignment (Figure 1d), 
and/or the consequential recurrent and chronic sleep deficiency. Shift workers often experience 
impaired alertness and cognition including diminished attention, memory, and executive function3. 
Shift workers also experience psychosocial disruption and impaired emotion regulation, along with 
increased risk of depression.  
 
Circadian misalignment can also have profound adverse metabolic consequences1,2. Circadian 
misalignment and disturbed sleep are independent risk factors for developing obesity and diabetes4. 
As a component of circadian misalignment, the mistiming of food intake, i.e., during the biological 
night, has been shown to impair glucose tolerance, pancreatic beta cell function, and may reduce 
energy expenditure5. Extensive evidence also links shift work with numerous gastrointestinal 
disorders6.  
 
The circadian system influences cardiovascular function2,3, including blood pressure regulation, 
cardiac sympathovagal balance, platelet activation, and fibrinolysis. Circadian misalignment in shift 
work has also been linked to autoimmune disorders and impaired immune function. Other diseases 
that are associated with circadian misalignment and sleep disruption may be mediated by 
immunological mechanisms: heart disease, metabolic syndrome, stroke and cancers all share 
inflammation as a risk factor or modifier. There is also animal-based evidence of environmental 
circadian misalignment causing disruption to innate and adaptive immune processes, increasing 
susceptibility to cancer, sepsis, intestinal inflammation and early death7. Shift work was classified by 
the World Health Organization as a probable carcinogen, and this classification was recently re-
affirmed. 
 
Circadian misalignment also occurs in common clinical conditions of reduced light perception 
including ageing and diabetic retinopathy, and in Delayed and Advanced Sleep-Wake Phase Disorder, 
affecting many adolescents and older adults, respectively. Further, reduced contrast between day and 
night light exposure, increasingly prevalent due to indoor lifestyles, widespread artificial lighting, and 
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(blue) light-emitting electronics, weakens circadian synchronization and potentially promotes adverse 
health.  
 
Another manifestation of circadian misalignment, which has received much less attention, is Non-24-
h Sleep-Wake Disorder (N24SWD); typified by chronic circadian disruption due to an inability of the 
SCN to be synchronized by external time cues, (i.e., the light-dark cycle), and for which a 
pharmacological treatment has recently been FDA approved. This disorder is experienced by most 
totally blind individuals without light perception,8 although cases are also reported in sighted 
patients9.  
 
In N24SWD, since the endogenous circadian period (or cycle length) is typically slightly longer than 
24 hours, the pacemaker slowly drifts in and out of phase with the external environment. In only a 
minority of blind patients is this drifting of their endogenous circadian system matched by a parallel 
drifting of their habitual sleep-wake cycles. Most patients, however, attempt to sleep at night and 
remain awake during the day, to match work/school, and social schedules. In this way, what is 
thought to be the classical clinical presentation of N24SWD—a gradual, daily shifting of the timing of 
the sleep/wake cycle—is the exception. Instead, in most patients while they attempt to sleep at night, 
the pacemaker becomes misaligned from sleep-wake and other behavioral cycles on a cyclically 
recurring basis (Figure 1b), causing sleep disruption, daytime sleepiness and napping, and impaired 
mood. Because of the desynchrony between the sleep/wake cycle and the endogenous circadian 
pacemaker in the majority of cases, the condition is notoriously difficult to diagnose with diaries or 
wrist actigraphy, and instead requires repeated assessments of the melatonin rhythm spanning weeks 
or months8,10. 
 
Given the high prevalence of circadian misalignment in N24SWD, there is a need for future studies to 
better understand the pathophysiology and develop novel treatments in N24SWD, and other circadian 
disorders8. Clinical management guidelines are urgently needed to prevent, diagnose, and treat these 
highly prevalent circadian disorders and ultimately reduce their substantial healthcare burden.   
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Figure 1. Shift work and Non-24h Sleep-Wake Disorder have significant implications for 
adverse clinical health outcomes. (A) Example of shiftwork: behavioral, externally-driven circadian 
misalignment caused by the occupational requirements (adapted from 11). Blue hatched bars represent 
work episodes, white bars represent free time or sleep, filled circles (mean [SE]) represent the peak of 
melatonin as a marker of central circadian phase. With the change from working day shifts to night 
shifts, the circadian pacemaker is misaligned with the timing of work and sleep. (B) Examples of 
N24SWD: a chronic, intrinsically driven circadian disruption. Blue bars represent sleep episodes; 
filled circles represent the peak of melatonin or cortisol as markers of central circadian phase. The left 
panel illustrates what most clinicians consider is the typical manifestation of N24SWD, however, only 
a small proportion maintain entrainment between circadian and sleep cycles. The right panel 
illustrates that most patients are either not diagnosed or misdiagnosed (e.g., insomnia); because they 
don’t present with a non-24-h sleep-wake profile (adapted from 8). Circadian phase assessments are 
rarely conducted to confirm diagnoses. (C) The molecular mechanism generating endogenous 
circadian rhythms consists of intracellular transcriptional/translational positive and negative feedback 
loops involving a complex clock-gene regulatory network. Shift work and N24SWD both lead to 
circadian misalignment and sleep disruption. Circadian misalignment often manifests between 
behavioral and environmental cycles and the central pacemaker in the SCN and between behavioral 
and peripheral circadian oscillators found in virtually every organ and cell of the body. Internal 
desynchrony occurs between peripheral oscillators and the SCN, and among organs, cells and clock 
genes (adapted from 1). (D) Circadian misalignment and sleep disruption have been implicated in 
numerous adverse health outcomes.  
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